Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation
Abstract Background Posterior reversible encephalopathy syndrome (PRES) represents a transient change in mental status with associated vasogenic edema of cortical and subcortical brain structures. It is often attributed to multifactorial etiology including hypertension and altered hemodynamics and d...
Guardado en:
Autores principales: | Nicholas Dietz, Zarmina Mufti, Muhammed Yousaf, Randal Brown, Christopher Counts, Martin F. Bjurström, Brian J. Williams, David Robertson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f9730d8944384865afd777ad19ebc271 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection
por: Esmaeil KhanMohammadi, et al.
Publicado: (2021) -
The Efficacy of the Interferon Alpha/Beta Response versus Arboviruses Is Temperature Dependent
por: Whitney C. Lane, et al.
Publicado: (2018) -
Journal of interferon & cytokine research the official journal of the International Society for Interferon and Cytokine Research.
Publicado: (1995) -
Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review
por: Abuzar A. Asif, et al.
Publicado: (2021) -
A Novel Mycovirus Evokes Transcriptional Rewiring in the Fungus <italic toggle="yes">Malassezia</italic> and Stimulates Beta Interferon Production in Macrophages
por: Shelly Applen Clancey, et al.
Publicado: (2020)